Medical Care

Global Regadenoson Injection Market Research Report 2025

The global market for Regadenoson Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Regadenoson Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Regadenoson Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Regadenoson Injection in Imaging Loading Drugs is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Regadenoson Injection include Astellas Pharma, Glenmark Pharmaceuticals, Gilead Sciences, Kingfriend, Heron Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Regadenoson Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regadenoson Injection.
The Regadenoson Injection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regadenoson Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regadenoson Injection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma
Glenmark Pharmaceuticals
Gilead Sciences
Kingfriend
Heron Pharma
Segment by Type
Original Drug
Generic Drug
Segment by Application
Imaging Loading Drugs
Disease Testing Agent
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regadenoson Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regadenoson Injection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Regadenoson Injection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Imaging Loading Drugs
1.3.3 Disease Testing Agent
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Regadenoson Injection Market Perspective (2020-2031)
2.2 Global Regadenoson Injection Growth Trends by Region
2.2.1 Global Regadenoson Injection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Regadenoson Injection Historic Market Size by Region (2020-2025)
2.2.3 Regadenoson Injection Forecasted Market Size by Region (2026-2031)
2.3 Regadenoson Injection Market Dynamics
2.3.1 Regadenoson Injection Industry Trends
2.3.2 Regadenoson Injection Market Drivers
2.3.3 Regadenoson Injection Market Challenges
2.3.4 Regadenoson Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regadenoson Injection Players by Revenue
3.1.1 Global Top Regadenoson Injection Players by Revenue (2020-2025)
3.1.2 Global Regadenoson Injection Revenue Market Share by Players (2020-2025)
3.2 Global Regadenoson Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Regadenoson Injection Revenue
3.4 Global Regadenoson Injection Market Concentration Ratio
3.4.1 Global Regadenoson Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regadenoson Injection Revenue in 2024
3.5 Global Key Players of Regadenoson Injection Head office and Area Served
3.6 Global Key Players of Regadenoson Injection, Product and Application
3.7 Global Key Players of Regadenoson Injection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Regadenoson Injection Breakdown Data by Type
4.1 Global Regadenoson Injection Historic Market Size by Type (2020-2025)
4.2 Global Regadenoson Injection Forecasted Market Size by Type (2026-2031)
5 Regadenoson Injection Breakdown Data by Application
5.1 Global Regadenoson Injection Historic Market Size by Application (2020-2025)
5.2 Global Regadenoson Injection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Regadenoson Injection Market Size (2020-2031)
6.2 North America Regadenoson Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Regadenoson Injection Market Size by Country (2020-2025)
6.4 North America Regadenoson Injection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Regadenoson Injection Market Size (2020-2031)
7.2 Europe Regadenoson Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Regadenoson Injection Market Size by Country (2020-2025)
7.4 Europe Regadenoson Injection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Regadenoson Injection Market Size (2020-2031)
8.2 Asia-Pacific Regadenoson Injection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Regadenoson Injection Market Size by Region (2020-2025)
8.4 Asia-Pacific Regadenoson Injection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Regadenoson Injection Market Size (2020-2031)
9.2 Latin America Regadenoson Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Regadenoson Injection Market Size by Country (2020-2025)
9.4 Latin America Regadenoson Injection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regadenoson Injection Market Size (2020-2031)
10.2 Middle East & Africa Regadenoson Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Regadenoson Injection Market Size by Country (2020-2025)
10.4 Middle East & Africa Regadenoson Injection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Regadenoson Injection Introduction
11.1.4 Astellas Pharma Revenue in Regadenoson Injection Business (2020-2025)
11.1.5 Astellas Pharma Recent Development
11.2 Glenmark Pharmaceuticals
11.2.1 Glenmark Pharmaceuticals Company Details
11.2.2 Glenmark Pharmaceuticals Business Overview
11.2.3 Glenmark Pharmaceuticals Regadenoson Injection Introduction
11.2.4 Glenmark Pharmaceuticals Revenue in Regadenoson Injection Business (2020-2025)
11.2.5 Glenmark Pharmaceuticals Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Regadenoson Injection Introduction
11.3.4 Gilead Sciences Revenue in Regadenoson Injection Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Kingfriend
11.4.1 Kingfriend Company Details
11.4.2 Kingfriend Business Overview
11.4.3 Kingfriend Regadenoson Injection Introduction
11.4.4 Kingfriend Revenue in Regadenoson Injection Business (2020-2025)
11.4.5 Kingfriend Recent Development
11.5 Heron Pharma
11.5.1 Heron Pharma Company Details
11.5.2 Heron Pharma Business Overview
11.5.3 Heron Pharma Regadenoson Injection Introduction
11.5.4 Heron Pharma Revenue in Regadenoson Injection Business (2020-2025)
11.5.5 Heron Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Regadenoson Injection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Original Drug
Table 3. Key Players of Generic Drug
Table 4. Global Regadenoson Injection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Regadenoson Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Regadenoson Injection Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Regadenoson Injection Market Share by Region (2020-2025)
Table 8. Global Regadenoson Injection Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Regadenoson Injection Market Share by Region (2026-2031)
Table 10. Regadenoson Injection Market Trends
Table 11. Regadenoson Injection Market Drivers
Table 12. Regadenoson Injection Market Challenges
Table 13. Regadenoson Injection Market Restraints
Table 14. Global Regadenoson Injection Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Regadenoson Injection Market Share by Players (2020-2025)
Table 16. Global Top Regadenoson Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regadenoson Injection as of 2024)
Table 17. Ranking of Global Top Regadenoson Injection Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Regadenoson Injection Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Regadenoson Injection, Headquarters and Area Served
Table 20. Global Key Players of Regadenoson Injection, Product and Application
Table 21. Global Key Players of Regadenoson Injection, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Regadenoson Injection Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Regadenoson Injection Revenue Market Share by Type (2020-2025)
Table 25. Global Regadenoson Injection Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Regadenoson Injection Revenue Market Share by Type (2026-2031)
Table 27. Global Regadenoson Injection Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Regadenoson Injection Revenue Market Share by Application (2020-2025)
Table 29. Global Regadenoson Injection Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Regadenoson Injection Revenue Market Share by Application (2026-2031)
Table 31. North America Regadenoson Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Regadenoson Injection Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Regadenoson Injection Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Regadenoson Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Regadenoson Injection Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Regadenoson Injection Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Regadenoson Injection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Regadenoson Injection Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Regadenoson Injection Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Regadenoson Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Regadenoson Injection Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Regadenoson Injection Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Regadenoson Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Regadenoson Injection Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Regadenoson Injection Market Size by Country (2026-2031) & (US$ Million)
Table 46. Astellas Pharma Company Details
Table 47. Astellas Pharma Business Overview
Table 48. Astellas Pharma Regadenoson Injection Product
Table 49. Astellas Pharma Revenue in Regadenoson Injection Business (2020-2025) & (US$ Million)
Table 50. Astellas Pharma Recent Development
Table 51. Glenmark Pharmaceuticals Company Details
Table 52. Glenmark Pharmaceuticals Business Overview
Table 53. Glenmark Pharmaceuticals Regadenoson Injection Product
Table 54. Glenmark Pharmaceuticals Revenue in Regadenoson Injection Business (2020-2025) & (US$ Million)
Table 55. Glenmark Pharmaceuticals Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Regadenoson Injection Product
Table 59. Gilead Sciences Revenue in Regadenoson Injection Business (2020-2025) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Kingfriend Company Details
Table 62. Kingfriend Business Overview
Table 63. Kingfriend Regadenoson Injection Product
Table 64. Kingfriend Revenue in Regadenoson Injection Business (2020-2025) & (US$ Million)
Table 65. Kingfriend Recent Development
Table 66. Heron Pharma Company Details
Table 67. Heron Pharma Business Overview
Table 68. Heron Pharma Regadenoson Injection Product
Table 69. Heron Pharma Revenue in Regadenoson Injection Business (2020-2025) & (US$ Million)
Table 70. Heron Pharma Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
Table 74. Authors List of This Report


List of Figures
Figure 1. Regadenoson Injection Picture
Figure 2. Global Regadenoson Injection Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Regadenoson Injection Market Share by Type: 2024 VS 2031
Figure 4. Original Drug Features
Figure 5. Generic Drug Features
Figure 6. Global Regadenoson Injection Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Regadenoson Injection Market Share by Application: 2024 VS 2031
Figure 8. Imaging Loading Drugs Case Studies
Figure 9. Disease Testing Agent Case Studies
Figure 10. Others Case Studies
Figure 11. Regadenoson Injection Report Years Considered
Figure 12. Global Regadenoson Injection Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Regadenoson Injection Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Regadenoson Injection Market Share by Region: 2024 VS 2031
Figure 15. Global Regadenoson Injection Market Share by Players in 2024
Figure 16. Global Top Regadenoson Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regadenoson Injection as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Regadenoson Injection Revenue in 2024
Figure 18. North America Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Regadenoson Injection Market Share by Country (2020-2031)
Figure 20. United States Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Regadenoson Injection Market Share by Country (2020-2031)
Figure 24. Germany Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Regadenoson Injection Market Share by Region (2020-2031)
Figure 32. China Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Regadenoson Injection Market Share by Country (2020-2031)
Figure 40. Mexico Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Regadenoson Injection Market Share by Country (2020-2031)
Figure 44. Turkey Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Regadenoson Injection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Astellas Pharma Revenue Growth Rate in Regadenoson Injection Business (2020-2025)
Figure 48. Glenmark Pharmaceuticals Revenue Growth Rate in Regadenoson Injection Business (2020-2025)
Figure 49. Gilead Sciences Revenue Growth Rate in Regadenoson Injection Business (2020-2025)
Figure 50. Kingfriend Revenue Growth Rate in Regadenoson Injection Business (2020-2025)
Figure 51. Heron Pharma Revenue Growth Rate in Regadenoson Injection Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies